Literature DB >> 18690971

Zolpidem and traffic safety - the importance of treatment compliance.

Joris C Verster1, Edmund R Volkerts, Berend Olivier, William Johnson, Laura Liddicoat.   

Abstract

Zolpidem is among the most frequently prescribed hypnotic drugs for those who suffer from insomnia. Recent media reports drew attention to driving impairment after zolpidem misuse. This review summarizes the available data on the effects of recommended use and misuse of zolpidem on driving ability and traffic safety. Both experimental studies and roadside evidence were taken into account. From these studies it must be concluded that patients should fully comply with the prescription instructions of zolpidem, i.e. to take the medication just prior to a full 8 hours of uninterrupted sleep. If this strategy is adopted, zolpidem is a safe alternative to benzodiazpine hypnotics and zopiclone who do show significant driving impairment the morning following bedtime administration. However, to ensure traffic safety higher dosages than recommended (10 mg) or allowing less than 8 hours between zolpidem intake and actual operation of a motor vehicle should be avoided.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18690971     DOI: 10.2174/157488607781668882

Source DB:  PubMed          Journal:  Curr Drug Saf        ISSN: 1574-8863


  14 in total

1.  A randomized, crossover, placebo-controlled clinical trial to assess the sensitivity of the CRCDS Mini-Sim to the next-day residual effects of zopiclone.

Authors:  Arthur A Simen; Cynthia Gargano; Jang-Ho Cha; Melissa Drexel; An Bautmans; Ingeborg Heirman; Tine Laethem; Thomas Hochadel; Lien Gheyle; Kim Bleys; Chan Beals; Aubrey Stoch; Gary G Kay; Arie Struyk
Journal:  Ther Adv Drug Saf       Date:  2015-06

2.  Prescription of Zolpidem and the Risk of Fatal Motor Vehicle Collisions: A Population-Based, Case-Crossover Study from South Korea.

Authors:  Bo Ram Yang; Ye-Jee Kim; Mi-Sook Kim; Sun-Young Jung; Nam-Kyong Choi; Byungkwan Hwang; Byung-Joo Park; Joongyub Lee
Journal:  CNS Drugs       Date:  2018-06       Impact factor: 5.749

Review 3.  Patterns of Zolpidem Use in Male and Female Veterans Following Revised FDA Dosing Guidelines.

Authors:  Sabra S Inslicht; Thomas C Neylan
Journal:  J Clin Sleep Med       Date:  2018-07-15       Impact factor: 4.062

4.  Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects.

Authors:  Monique A J Mets; Juna M de Vries; Lieke M de Senerpont Domis; Edmund R Volkerts; Berend Olivier; Joris C Verster
Journal:  Sleep       Date:  2011-10-01       Impact factor: 5.849

Review 5.  The relationship between benzodiazepine use and traffic accidents: A systematic literature review.

Authors:  Beitske E Smink; Antoine C G Egberts; Klaas J Lusthof; Donald R A Uges; Johan J de Gier
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

6.  Middle-of-the-night hypnotic use in a large national health plan.

Authors:  Thomas Roth; Patricia Berglund; Victoria Shahly; Alicia C Shillington; Judith J Stephenson; Ronald C Kessler
Journal:  J Clin Sleep Med       Date:  2013-07-15       Impact factor: 4.062

Review 7.  Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence.

Authors:  Tharaka Dassanayake; Patricia Michie; Gregory Carter; Alison Jones
Journal:  Drug Saf       Date:  2011-02-01       Impact factor: 5.606

Review 8.  Medication use and the risk of motor vehicle collisions among licensed drivers: A systematic review.

Authors:  Toni M Rudisill; Motao Zhu; George A Kelley; Courtney Pilkerton; Brandon R Rudisill
Journal:  Accid Anal Prev       Date:  2016-08-29

9.  Responsiveness of Veterans Affairs Health Care System to Zolpidem Safety Warnings.

Authors:  Hyungjin Myra Kim; Lauren B Gerlach; Matheos Yosef; Claire Stano; Deirdre A Conroy; Marcia Valenstein; Paul N Pfeiffer; Anne E Sales; Kara Zivin
Journal:  J Clin Sleep Med       Date:  2018-07-15       Impact factor: 4.062

Review 10.  Psychoactive medication and traffic safety.

Authors:  Joris C Verster; Monique A J Mets
Journal:  Int J Environ Res Public Health       Date:  2009-03-10       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.